Ask our AI-chatbot
Planned

Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)

Published 30 Oct 2025

Download
Published 30 Oct 2025
Download
Financial schemeJoint transnational calls
ProgramEuropean Partnership for Personalised Medicine
Date call is made active1 November 2025
Deadline for pre-proposal submission10 February 2026, 14:00 CET
Deadline for full proposal submission9 June 2026, 14:00 CEST
Relevant thematic areas for this callHealth
Target groupsPublic sector, Industry, Research organisations
Contact person
Karianne SolaasHelse og offentlig sektorkso@forskningsradet.no
With this JTC, EP PerMed will fund research projects in human health on innovative PM strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination.

Proposals should address one or more of the following aspects:

  • Innovative personalised therapeutic approaches
  • Monitoring of treatment response in patients in order to tailor treatment pathways
  • Early disease risk prediction and prevention of disease worsening or comorbidities.

SME or other industrial partner is funded with up to 50% of their eligible project costs (see details in the State Aid rules, Article 25). All applicants and partners must comply with the State Aid rules. All projects are to be carried out as effective collaboration between the partners. Undertakings (companies) that participate in the consortium must also not receive indirect state aid in the form of advantageous conditions for cooperation with the research institutions taking part in the consortium. More information: Conditions for awarding state aid 

Website: https://www.eppermed.eu/funding-projects/calls/jtc2026/

Messages at time of print 30 October 2025, 16:29 CET

No global messages displayed at time of print.